Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (7)
  • 2025 (69)
  • 2024 (61)
  • 2023 (58)
  • 2022 (70)
  • 2021 (77)
  • 2020 (84)
  • 2019 (93)
  • 2018 (88)
  • 2017 (100)
  • 2016 (72)
  • 2015 (75)
  • 2014 (112)
  • 2013 (124)
  • 2012 (47)
  • 2011 (119)

Subject

  • Drug Trafficking (132)
  • Synthetic drugs (125)
  • Arrests/Convictions - Major (54)
  • Guns/Weapons (37)
  • Prescription Drugs (35)
  • Seizures (Drugs/Property) (30)
  • Take Back Day (30)
  • Fake Pills (26)
  • Outreach/Drug Prevention (25)
  • Major Law Enforcement Operation (22)
  • Guilty Plea (21)
  • Public and Media Affairs - also see Congressional Affairs (18)
  • Diversion Division (17)
  • Pharmaceuticals/Pharmacists/Physicians (16)
  • Overdose (15)
  • OCDETF/Task Force (14)
  • Congressional Affairs (13)
  • Money Laundering (13)
  • Fentanyl Awareness (12)
  • Gangs (12)
  • Press Conferences (11)
  • Extraditions (10)
  • Red Ribbon (9)
  • One Pill Can Kill (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Fentanyl Free America (7)
  • Task Forces/Task Force Officers (6)
  • Narcoterrorism (5)
  • Critical Incident (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Campaigns (3)
  • Counterfeit Pills (3)
  • Dark Web- Internet Trafficking (3)
  • Terrorism (3)
  • HIDTA (2)
  • Scam Calls (2)
  • Asset Forfeiture (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (167)
  • Methamphetamine (135)
  • Heroin (72)
  • Cocaine (66)
  • Marijuana (Cannabis) (26)
  • Oxycodone (19)
  • Opioids (11)
  • Synthetic Opioids (6)
  • Ecstasy/MDMA (5)
  • Marijuana Concentrates (5)
  • Ketamine (4)
  • LSD (2)
  • GHB (1)
  • K2/Spice (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • Miami (840)
  • Seattle (813)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribe (79)
  • Caribe (1)
  • San Francisco (847)
  • Sede (414)
Clear All Results
1256 Results - Showing 541 to 550
PRESS RELEASE

Two charged with methamphetamine distribution conspiracy, firearms violations, and assault on a federal officer

FRESNO, Calif. — A federal grand jury returned a six-count indictment today against Ruben Gonzalo Duran-Sanchez, 42, and Daniel Delgado, 27, both Mexican nationals, charging them with conspiracy to distribute and possess with intent to distribute methamphetamine and possession of firearms in furtherance of a drug trafficking offense, U.S. Attorney...
PRESS RELEASE

DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...
PRESS RELEASE

Santa Rosa doctor indicted for unlawfully prescribing fentanyl and oxycodone

SAN FRANCISCO – A federal grand jury indicted Santa Rosa doctor Thomas Keller, charging him with distributing Schedule II and IV controlled substances outside the scope of his professional practice and without a legitimate medical need, announced United States Attorney Alex G. Tse, Drug Enforcement Administration (DEA) Special Agent in...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...
PRESS RELEASE

Alameda resident sentenced for selling prescription drugs without a license and related charges

SAN FRANCISCO – Kenzo Mateo Tokuda was sentenced to 69 months in prison for possessing with intent to distribute alprazolam (commonly known as “Xanax”) and carrying a firearm during and in relation to a drug trafficking crime, announced United States Attorney Alex G. Tse and Drug Enforcement Administration Special Agent...
PRESS RELEASE

Mexican national residing in Modesto is sentenced to 17.5 years in prison for methamphetamine trafficking

SACRAMENTO, Calif. — Feliciano Ochoa Reyes, 34, of Mexico and Modesto was sentenced today by U.S. District Judge Garland E. Burrell, Jr. to 17-and-a-half years in prison for conspiring to distribute methamphetamine, U.S. Attorney McGregor W. Scott and U.S. Drug Enforcement Administration Special Agent in Charge Chris Nielsen announced. According...
PRESS RELEASE

Former medical doctor sentenced to over three years prison for unlawfully prescribing oxycodone

SAN FRANCISCO – United States Attorney Alex G. Tse and U.S. Drug Enforcement Administration Special Agent in Charge Chris Nielsen announced that Christopher Owens was sentenced to 41 months in prison for unlawfully prescribing oxycodone hydrochloride without a medical purpose. Owens pleaded guilty on March 20, 2018. According to his...
PRESS RELEASE

Two Afghan heroin traffickers sentenced in Manhattan federal court for conspiring to import heroin into the United States

NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

Justice Department announces release of new fentanyl safety video for first responders

WASHINGTON – The Office of Justice Programs’ Bureau of Justice Assistance today released the Fentanyl Safety Recommendations for First Responders’ companion training video Fentanyl: The Real Deal. The video was produced by U.S. Customs and Border Protection to help first responders protect themselves when the presence of fentanyl is suspected...

Paginación

  • Primera página «
  • Anterior
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Current page 55
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster